Niflactol Topico indications
Oral
Pain and inflammation associated with musculoskeletal and joint disorders
Adult: 250 mg 3 or 4 times daily. Max: 1500 mg daily.
Topical/Cutaneous
Pain and inflammation associated with musculoskeletal and joint disorders
Adult: 3% cream or ointment or 2.5% gel to be applied to affected areas.
Niflactol Topico description
An analgesic and anti-inflammatory agent used in the treatment of rheumatoid arthritis. [PubChem]
Niflactol Topico dosage
Oral
Pain and inflammation associated with musculoskeletal and joint disorders
Adult: 250 mg 3 or 4 times daily. Max: 1500 mg daily.
Topical/Cutaneous
Pain and inflammation associated with musculoskeletal and joint disorders
Adult: 3% cream or ointment or 2.5% gel to be applied to affected areas.
Niflactol Topico interactions
May increase concentration of methotrexate, cardiac glycosides. Increased risk of nephrotoxicity with ACE inhibitors, ciclosporin, tacrolimus, diuretics. Increased risk of GI bleeding with corticosteroids, SSRIs, venlafaxine, clopidogrel, ticlopidine, iloprost, erlotinib, sibutramine, alcohol, bisphosphonates, pentoxifylline.
Potentially Fatal: May reduce lithium excretion leading to lithium toxicity. May increase effects of anticoagulants.
Niflactol Topico side effects
CNS disturbances, hypersensitivity reactions, renal/hepatic disorders, GI disturbances, cutaneous reactions, agranulocytosis, neutropenia. Fluid retention, photosensitivity, alveolitis, pulmonary eosinophilia, pancreatitis, Stevens-Johnson syndrome, exacerbation of colitis.
Niflactol Topico contraindications
Active peptic ulceration, severe heart failure.
Active ingredient matches for Niflactol Topico:
Niflumic Acid in Spain.
List of Niflactol Topico substitutes (brand and generic names) | Sort by popularity |
| Unit description / dosage (Manufacturer) | Price, USD |
| Coan (Taiwan) | |
| Coan / S.C. 250 mg x 1000's | |
| Coan / S.C. 30 mg/1 g x 15 g | |
| Coan / S.C. 30 mg/1 g x 30 g | |
| Coan / S.C. 30 mg/1 g x 450 g | |
| Donalgin (Hungary) | |
| Capsule; Oral; Niflumic Acid 250 mg (Gedeon richter) | |
| Donalgin 250 mg (Hungary) | |
| Flogovital (Argentina) | |
| Flucidal (Algeria) | |
| Flunir (France) | |
| Forenol | |
| Inflocine (Tunisia) | |
|
sponsored
| |
| Inflocine adulte (Tunisia) | |
| Inflocine enfant (Tunisia) | |
| Landruma (Spain) | |
| Nifan (Taiwan) | |
| Nifan 250 mg | |
| Niflamol (Greece) | |
| Niflan Programmi Sanitari (Italy) | |
| Niflucil (Taiwan) | |
| Niflucil 250 mg | |
| Nifluderm (Tunisia) | |
| Niflugel (Algeria, Belgium, Benin, Burkina Faso, Burundi, Cameroon, Central African Republic, Chad, Congo, Cote D'ivoire, Czech Republic, France, Gabon, Guinea, Luxembourg, Madagascar, Mali, Mauritania, Mauritius, Myanmar, Niger, Romania, Senegal, Togo, Tunisia, Zaire) | |
| Gel; Local; Niflumic Acid 2.5% (Bristol myers squibb) | |
| Niflugel 2.5 % x 60 g (Bristol myers squibb) | |
| Niflugel 2.5% (France) | |
| Niflugel 2.5g/100g (Luxembourg) | |
| Nifluma 2.5% (Egypt) | |
| Niflumic (Tunisia) | |
| Niflumic Acid (Algeria, Benin, Burkina Faso, Burundi, Cameroon, Central African Republic, Chad, Congo, Cote D'ivoire, Czech Republic, France, Gabon, Guinea, Luxembourg, Madagascar, Mali, Mauritania, Mauritius, Myanmar, Niger, Oman, Portugal, Senegal, Taiwan, Togo, Tunisia, Zaire) | |
| Nifluril adulte (Tunisia) | |
| Nifluril Bb Farma (Italy) | |
| Nifluril Children (Lebanon) | |
| Nifluril Cream (Vietnam) | |
| Nifluril Cream 3 % x 60 g | |
| Nifluril enfant (Tunisia) | |
| Nifluril Farma 1000 (Italy) | |
| Nifluril Oint (Taiwan) | |
| Nifluril Ointment (Taiwan) | |
| Nifluril Ointment 3 % x 30 g | |
| Nifluril Ointment 3 % x 60 g | |
| Nifu (Taiwan) | |
| Nifu 250 mg | |
| Nifupan (Taiwan) | |
| Nifupan 25 mg/1 g | |
| Nijasyn (Taiwan) | |
| Nijasyn 250 mg | |
| Novopone (Greece) | |
| Nyciton (Taiwan) | |
| Nyciton 250 mg | |
| Nysul (Taiwan) | |
| Nysul 30 mg/1 g x 10 g | |
See 42 substitutes for Niflactol Topico | |
References
- PubChem. "niflumic acid". https://pubchem.ncbi.nlm.nih.gov/com... (accessed September 17, 2018).
- DrugBank. "niflumic acid". http://www.drugbank.ca/drugs/DB04552 (accessed September 17, 2018).
- DTP/NCI. "niflumic acid: The NCI Development Therapeutics Program (DTP) provides services and resources to the academic and private-sector research communities worldwide to facilitate the discovery and development of new cancer therapeutic agents.". https://dtp.cancer.gov/dtpstandard/s... (accessed September 17, 2018).
Reviews
The results of a survey conducted on ndrugs.com for Niflactol Topico are given in detail below. The results of the survey conducted are based on the impressions and views of the website users and consumers taking Niflactol Topico. We implore you to kindly base your medical condition or therapeutic choices on the result or test conducted by a physician or licensed medical practitioners.User reports
1 consumer reported useful
Was the Niflactol Topico drug useful in terms of decreasing the symptom or the disease?According to the reports released by ndrugs.com website users, the below mentioned percentages of users say the drug is useful / not useful to them in decreasing their symptoms/disease. The usefulness of the drug depends on many factors, like severity of the disease, perception of symptom, or disease by the patient, brand name used [matters only to a certain extent], other associated conditions of the patient. If the drug is not effective or useful in your case, you need to meet the doctor to get re-evaluated about your symptoms/disease, and he will prescribe an alternative drug.
| Users | % | ||
|---|---|---|---|
| Useful | 1 | 100.0% | |
Consumer reported price estimates
No survey data has been collected yetConsumer reported time for results
No survey data has been collected yet2 consumers reported age
| Users | % | ||
|---|---|---|---|
| > 60 | 1 | 50.0% | |
| 46-60 | 1 | 50.0% | |
Consumer reviews
There are no reviews yet. Be the first to write one! |
Information checked by Dr. Sachin Kumar, MD Pharmacology
